These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7038911)

  • 1. [Production of typhoid vaccine by fermentation].
    Medina A; Recamier L; Martín T
    Salud Publica Mex; 1981; 23(6):657-64. PubMed ID: 7038911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors affecting potency during the production of typhoid vaccine].
    Porras Lanzagorta M; Montesinos FN; González Pacheco M
    Salud Publica Mex; 1981; 23(6):633-40. PubMed ID: 7038910
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccine production as a unit process.
    van Hemert P
    Prog Ind Microbiol; 1974; 13():151-271. PubMed ID: 4373785
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production of typhoid vaccine by the Zagreb method].
    Sańchez PE; Galicia AO
    Salud Publica Mex; 1981; 23(6):641-7. PubMed ID: 7336287
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenic activity of typhoid bacteria following various regimes of continuous culturing].
    Zhdanova LG; Gruber IM; Basnak'ian IA; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):22-6. PubMed ID: 4911521
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the immunological activity with the chemical makeup and synthesis of Vi, O and H antigens of typhoid bacteria at different phases of stab cultivation].
    Zhdanova LG; Savranskaia SI; Mashilova GM; Gruber IM; Shandalov BI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):99-105. PubMed ID: 4615524
    [No Abstract]   [Full Text] [Related]  

  • 7. [Properties of 2 gal+ derivatives of the vaccine mutant gal E Ty21a strain of Salmonella typhi].
    Silva-Salinas BA; Rodríguez-Aguayo L; Maldonado-Ballesteros A; Valenzuela-Montero ME; Seoane-Montecinos M
    Bol Med Hosp Infant Mex; 1985 Apr; 42(4):234-9. PubMed ID: 4005022
    [No Abstract]   [Full Text] [Related]  

  • 8. Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine.
    Lemercinier X; Martinez-Cabrera I; Jones C
    Biologicals; 2000 Mar; 28(1):17-24. PubMed ID: 10799051
    [No Abstract]   [Full Text] [Related]  

  • 9. [Optimization of culture conditions for the production of Salmonella typhi O and H antigenic suspensions].
    Amrouche M; Seddi R; Kadra B; Bakour R
    Arch Inst Pasteur Alger; 1992; 58():181-204. PubMed ID: 1285026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ISOLATION, CLASSIFICATION AND TYPING OF SALMONELLA TYPHI IN PATIENTS OF THE QUARANTINE HOSPITAL OF GUAYAQUIL].
    NEPTALIMUNOZ J
    Rev Ecuat Hig Med Trop; 1963; 20():19-35. PubMed ID: 14198869
    [No Abstract]   [Full Text] [Related]  

  • 11. Purified Vi antigens as possible typhoid vaccines.
    Pistole TG; Marcus S
    Immunol Commun; 1974; 3(3):227-38. PubMed ID: 4606971
    [No Abstract]   [Full Text] [Related]  

  • 12. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
    Hall CB
    Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
    [No Abstract]   [Full Text] [Related]  

  • 13. An experimental study of a typhoid vaccine inactivated with beta-propiolactone.
    Dimache G; Croitoru M; Dimache V; Petrovici A; Ciordaş C
    Arch Roum Pathol Exp Microbiol; 1985; 44(4):355-61. PubMed ID: 3838046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of various typhoid vaccines prepared by using different culture media].
    Dimache G; Teodorescu G; Croitoru M; Ciordaç C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1983; 28(2):187-91. PubMed ID: 6635467
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of two Salmonella typhosa mutants for a possible use as a live oral attenuated vaccinal strains.
    Dima VF
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):33-40. PubMed ID: 7185346
    [No Abstract]   [Full Text] [Related]  

  • 16. [The characteristics of an antigenic preparation from Salmonella typhi Ty(2)4446 isolated using hydroxylamine hydrochloride].
    Sergeev VV; Tsvetkova NV; Iastrebova NE; Kaverina KG; Ian'kova MM; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):65. PubMed ID: 8079573
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of immunologically active substances from Salmonella typhi.
    Joó I; Pusztai Z; Eckhardt EG; Jaszovszky I
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Oct; 131(4):352-65. PubMed ID: 4226440
    [No Abstract]   [Full Text] [Related]  

  • 18. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.